{
    "2021-09-10": [
        [
            {
                "time": "",
                "original_text": "康泰生物：杜伟民合计减持0.08%公司股份 减持股份",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "杜伟民",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：控股股东减持51.6万股，占总股本0.08% 减持股份",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "控股股东",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物13价肺炎疫苗获批，黄金疫苗市场争夺“三国杀”",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "13价肺炎疫苗",
                        "获批",
                        "市场争夺"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物(300601.SZ)实控人杜伟民减持期满 累计减持51.6万股 减持股份",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "杜伟民",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物跌7.24% 申银万国东吴证券高点喊买入",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "股价下跌",
                        "券商推荐"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物子公司获药品注册证书",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "子公司",
                        "药品注册证书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：收到13价肺炎球菌多糖结合疫苗药品注册证书",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "13价肺炎疫苗",
                        "药品注册证书"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物(300601.SZ)：13价肺炎球菌多糖结合疫苗获批上市",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "13价肺炎疫苗",
                        "获批上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "第二款国产13价肺炎疫苗！康泰生物“维民菲宝”获批上市",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "13价肺炎疫苗",
                        "维民菲宝",
                        "获批上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}